TSG101-GAG interaction and use thereof
US7335468B2 · kind B2 · utility
4Cited by
5References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 15, 2003 |
| Grant date | Feb 26, 2008 |
| Priority date | — |
| Expiry date | Apr 20, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/36222
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Isolated protein complexes are provided comprising Tsg101 and HIV GAG or GAGp6. The protein complexes are useful in screening assays for selecting compounds effective in modulating the Tsg101-HIV GAG or GAGp6 interaction within the protein complexes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.